Can someone please post the brokers analysis that is recommending TGR as a Strong Sell? Commsec has their name withheld. I would like to understand their rationale.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%